New Melanoma Stories

13 June 2013 In Melanoma Stories

Melanoma has touched the lives of many people, and MRA is always eager to hear melanoma stories from patients, researchers, family members, and everyone else affected by this disease. We've recently added two more must-read survivor stories to the MRA website, and here's a preview:

Read More


Two MRA-Sponsored Investigators Published Papers in the New England Journal of Medicine

12 June 2013 In News

Two MRA-sponsored investigators recently reported on the clinical testing of immune checkpoint inhibitors targeting a pathway known as PD-1 in the New England Journal of Medicine. This therapeutic approach, whose clinical utility was established by the FDA approval of ipilimumab in 2011, has produced promising data in patients with advanced melanoma.

Read More


Melanoma News Round-Up June 7, 2013

7 June 2013 In News

Promising New Cancer Drugs Empower the Body's Own Immune System via the New York Times MSK Researchers Report Major Advances in Treatment for Metastatic Eye and Skin Melanoma via Memorial Sloan Kettering Meet the New Class of Drugs Being Deployed in the the Struggle Against Cancer: Checkpoint Blockade via the Economist For a...

Read More


New Melanoma Therapies Approved

31 May 2013 In News

[caption id="attachment_200" align="aligncenter" width="576"] © Ladyminnie | Dreamstime Stock Photos & Stock Free Images[/caption] These are the best types of posts to write:  On Wednesday, the US Food and Drug Administration (FDA) approved two genetically-targeted melanoma therapies as well as a companion diagnostic test that will be used to determine...

Read More


Safe Sun Style: Guest Post from Meg of SPF Love

30 May 2013 In Allies & Partnerships

It's a common misconception that sun safety is not fashion-forward.  Our guest blogger and May ally SPF Love begs to differ. [caption id="attachment_203" align="aligncenter" width="300"] Meg of SPF Love[/caption] I'm honored to be guest blogging for MRA.  I started my journey over a year ago when I decided to start...

Read More


Wendy Selig Explains MRA's Focus on Collaboration

29 May 2013 In Allies & Partnerships

Listen to Wendy explain MRA's singular focus on collaboration and its transformative effect on awareness building and the drug development process! [youtube url=http://www.youtube.com/watch?v=NNYHqxtchlQ] This in an excerpt from a longer interview with m/Oppenheim Associates, an executive search firm that specializes in recruiting non-profit leaders.  You can watch the full interview here.

Read More


Melanoma News Round-Up May 24, 2013

24 May 2013 In News

Lots of MRA and melanoma news came out this past week; here are some highlights:

Read More


MRA CSO Louise Perkins Interviewed at BIO International Convention

20 May 2013 In Events

MRA recently attended the BIO International Convention, the biopharma industry's largest gathering of drug development professionals and decision-makers.  We exhibited and held meetings in the Advocacy Pavilion, and our CSO was featured in the BIO Buzz Center, where she and Lauren Neff, BIO's Director of Alliance Development, discussed MRA's mission and...

Read More


MRA & Leveraged Finance Fights Melanoma Video Series

19 May 2013 In Events

[brightcove vid=2372187009001&exp3=1405557362001&surl=http://c.brightcove.com/services&pubid=1405556719001&pk=AQ~~,AAABR0G1fZk~,HNsXz5NC104V7oLZ6aVapLmHmSUC2yKF&w=480&h=270] MRA is holding its 2nd annual Leveraged Finance Fights Melanoma event next week in NYC.  Our friends at Privcap produced a series of videos featuring people from the leveraged finance community who have been touched by melanoma.

Read More


Welcome!

By Wendy Selig, MRA President & CEO | 18 May 2013 In News

We are delighted to be launching the Melanoma Research Alliance (MRA) blog – welcome!  We felt the name Melanoma Focus had important significance because MRA is singularly focused on defeating melanoma and moving toward a day when no one suffers or dies from this deadly cancer.  And we know how...

Read More


Login

×